241 related articles for article (PubMed ID: 32156733)
1. Potent CRISPR-Cas9 inhibitors from
Watters KE; Shivram H; Fellmann C; Lew RJ; McMahon B; Doudna JA
Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6531-6539. PubMed ID: 32156733
[TBL] [Abstract][Full Text] [Related]
2. Broad-spectrum anti-CRISPR proteins facilitate horizontal gene transfer.
Mahendra C; Christie KA; Osuna BA; Pinilla-Redondo R; Kleinstiver BP; Bondy-Denomy J
Nat Microbiol; 2020 Apr; 5(4):620-629. PubMed ID: 32218510
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of Staphylococcus aureus Cas9 inhibition by AcrIIA14.
Liu H; Zhu Y; Lu Z; Huang Z
Nucleic Acids Res; 2021 Jun; 49(11):6587-6595. PubMed ID: 34107040
[TBL] [Abstract][Full Text] [Related]
4.
Yourik P; Fuchs RT; Mabuchi M; Curcuru JL; Robb GB
RNA; 2019 Jan; 25(1):35-44. PubMed ID: 30348755
[TBL] [Abstract][Full Text] [Related]
5. Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins.
Lee J; Mir A; Edraki A; Garcia B; Amrani N; Lou HE; Gainetdinov I; Pawluk A; Ibraheim R; Gao XD; Liu P; Davidson AR; Maxwell KL; Sontheimer EJ
mBio; 2018 Dec; 9(6):. PubMed ID: 30514786
[TBL] [Abstract][Full Text] [Related]
6. Temperature-Responsive Competitive Inhibition of CRISPR-Cas9.
Jiang F; Liu JJ; Osuna BA; Xu M; Berry JD; Rauch BJ; Nogales E; Bondy-Denomy J; Doudna JA
Mol Cell; 2019 Feb; 73(3):601-610.e5. PubMed ID: 30595438
[TBL] [Abstract][Full Text] [Related]
7. Discovery of potent and versatile CRISPR-Cas9 inhibitors engineered for chemically controllable genome editing.
Song G; Zhang F; Tian C; Gao X; Zhu X; Fan D; Tian Y
Nucleic Acids Res; 2022 Mar; 50(5):2836-2853. PubMed ID: 35188577
[TBL] [Abstract][Full Text] [Related]
8. Computational design of anti-CRISPR proteins with improved inhibition potency.
Mathony J; Harteveld Z; Schmelas C; Upmeier Zu Belzen J; Aschenbrenner S; Sun W; Hoffmann MD; Stengl C; Scheck A; Georgeon S; Rosset S; Wang Y; Grimm D; Eils R; Correia BE; Niopek D
Nat Chem Biol; 2020 Jul; 16(7):725-730. PubMed ID: 32284602
[TBL] [Abstract][Full Text] [Related]
9. Functional metagenomics-guided discovery of potent Cas9 inhibitors in the human microbiome.
Forsberg KJ; Bhatt IV; Schmidtke DT; Javanmardi K; Dillard KE; Stoddard BL; Finkelstein IJ; Kaiser BK; Malik HS
Elife; 2019 Sep; 8():. PubMed ID: 31502535
[TBL] [Abstract][Full Text] [Related]
10. Cas9 degradation in human cells using phage anti-CRISPR proteins.
Meacham Z; de Tacca LA; Bondy-Denomy J; Rabuka D; Schelle M
PLoS Biol; 2023 Dec; 21(12):e3002431. PubMed ID: 38064533
[TBL] [Abstract][Full Text] [Related]
11. Solution structure and dynamics of anti-CRISPR AcrIIA4, the Cas9 inhibitor.
Kim I; Jeong M; Ka D; Han M; Kim NK; Bae E; Suh JY
Sci Rep; 2018 Mar; 8(1):3883. PubMed ID: 29497118
[TBL] [Abstract][Full Text] [Related]
12. DNA rehybridization drives product release from Cas9 ribonucleoprotein to enable multiple-turnover cleavage.
Pan J; Mabuchi M; Robb GB
Nucleic Acids Res; 2023 May; 51(8):3903-3917. PubMed ID: 37014013
[TBL] [Abstract][Full Text] [Related]
13. Rationally Designed Anti-CRISPR Nucleic Acid Inhibitors of CRISPR-Cas9.
Barkau CL; O'Reilly D; Rohilla KJ; Damha MJ; Gagnon KT
Nucleic Acid Ther; 2019 Jun; 29(3):136-147. PubMed ID: 30990769
[TBL] [Abstract][Full Text] [Related]
14. Machine learning predicts new anti-CRISPR proteins.
Eitzinger S; Asif A; Watters KE; Iavarone AT; Knott GJ; Doudna JA; Minhas FUAA
Nucleic Acids Res; 2020 May; 48(9):4698-4708. PubMed ID: 32286628
[TBL] [Abstract][Full Text] [Related]
15. Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type IIC Anti-CRISPR Proteins.
Zhu Y; Gao A; Zhan Q; Wang Y; Feng H; Liu S; Gao G; Serganov A; Gao P
Mol Cell; 2019 Apr; 74(2):296-309.e7. PubMed ID: 30850331
[TBL] [Abstract][Full Text] [Related]
16. Allosteric inhibition of CRISPR-Cas9 by bacteriophage-derived peptides.
Cui YR; Wang SJ; Chen J; Li J; Chen W; Wang S; Meng B; Zhu W; Zhang Z; Yang B; Jiang B; Yang G; Ma P; Liu J
Genome Biol; 2020 Feb; 21(1):51. PubMed ID: 32102684
[TBL] [Abstract][Full Text] [Related]
17. All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo.
Ibraheim R; Song CQ; Mir A; Amrani N; Xue W; Sontheimer EJ
Genome Biol; 2018 Sep; 19(1):137. PubMed ID: 30231914
[TBL] [Abstract][Full Text] [Related]
18. Widespread anti-CRISPR proteins in virulent bacteriophages inhibit a range of Cas9 proteins.
Hynes AP; Rousseau GM; Agudelo D; Goulet A; Amigues B; Loehr J; Romero DA; Fremaux C; Horvath P; Doyon Y; Cambillau C; Moineau S
Nat Commun; 2018 Jul; 9(1):2919. PubMed ID: 30046034
[TBL] [Abstract][Full Text] [Related]
19. The initiation, propagation and dynamics of CRISPR-SpyCas9 R-loop complex.
Zeng Y; Cui Y; Zhang Y; Zhang Y; Liang M; Chen H; Lan J; Song G; Lou J
Nucleic Acids Res; 2018 Jan; 46(1):350-361. PubMed ID: 29145633
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of the anti-CRISPR, AcrIIC4.
Kim GE; Lee SY; Park HH
Protein Sci; 2021 Dec; 30(12):2474-2481. PubMed ID: 34676610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
